Delaware | 000-06920 | 94-1655526 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
3050 Bowers Avenue | ||
P.O. Box 58039 | ||
Santa Clara, CA | 95052-8039 | |
(Address of principal executive | (Zip Code) | |
offices) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition | ||||||||
Item 9.01 Financial Statements and Exhibits | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
EXHIBIT 99.1 |
Exhibit No. | Description | |
99.1
|
Press Release issued by Applied Materials, Inc. dated May 13, 2008. |
Applied Materials, Inc. (Registrant) |
||||||||
Date: May 13, 2008 |
||||||||
By: | /s/ Joseph J. Sweeney
Senior Vice President, General Counsel and Corporate Secretary |
Exhibit No. | Description | |
99.1
|
Press Release issued by Applied Materials, Inc. dated May 13, 2008. |
Release:
|
Immediate | |||
Contact:
|
Linda Heller (investment community) | David Miller (editorial/media) | ||
(408) 986-7977 | (408) 563-9582 |
| Net Sales: $2.15 billion (15% decrease year over year; 3% increase quarter over quarter) | |
| Net Income: $303 million (26% decrease year over year; 15% increase quarter over quarter) | |
| EPS: $0.22 ($0.07 decrease year over year; $0.03 increase quarter over quarter) | |
| New Orders: $2.41 billion (9% decrease year over year; 3% decrease quarter over quarter) |
Three Months Ended | Three Months Ended | Three Months Ended | ||||||||||||||||||||||||||||||||||
April 27, 2008 | January 27, 2008 | April 29, 2007 | ||||||||||||||||||||||||||||||||||
Operating | Operating | Operating | ||||||||||||||||||||||||||||||||||
New | Net | Income | New | Net | Income | New | Net | Income | ||||||||||||||||||||||||||||
(In millions) | Orders | Sales | (Loss) | Orders | Sales | (Loss) | Orders | Sales | (Loss) | |||||||||||||||||||||||||||
Silicon |
$ | 1,061 | $ | 1,268 | $ | 448 | $ | 1,075 | $ | 1,237 | $ | 445 | $ | 1,939 | $ | 1,738 | $ | 606 | ||||||||||||||||||
Applied Global
Services |
602 | 599 | 159 | 610 | 595 | 149 | 586 | 589 | 157 | |||||||||||||||||||||||||||
Display |
493 | 198 | 59 | 555 | 133 | 34 | 60 | 160 | 28 | |||||||||||||||||||||||||||
Energy and
Environmental
Solutions |
257 | 85 | (71 | ) | 260 | 122 | (48 | ) | 63 | 43 | (15 | ) |
Three Months Ended | Six Months Ended | |||||||||||||||
April 27, | April 29, | April 27, | April 29, | |||||||||||||
(In thousands, except per share amounts) | 2008 | 2007 | 2008 | 2007 | ||||||||||||
Net sales |
$ | 2,149,998 | $ | 2,529,561 | $ | 4,237,395 | $ | 4,806,828 | ||||||||
Cost of products sold |
1,183,170 | 1,392,951 | 2,335,586 | 2,607,680 | ||||||||||||
Gross margin |
966,828 | 1,136,610 | 1,901,809 | 2,199,148 | ||||||||||||
Operating expenses: |
||||||||||||||||
Research, development and engineering |
287,122 | 291,044 | 560,341 | 578,611 | ||||||||||||
Marketing and selling |
119,410 | 112,107 | 243,327 | 219,019 | ||||||||||||
General and administrative |
122,035 | 119,391 | 238,011 | 241,202 | ||||||||||||
Restructuring and asset impairments |
510 | 25,044 | 49,496 | 21,766 | ||||||||||||
Income from operations |
437,751 | 589,024 | 810,634 | 1,138,550 | ||||||||||||
Pre-tax loss of equity method investment |
9,766 | 5,924 | 19,352 | 9,861 | ||||||||||||
Interest expense |
6,256 | 8,845 | 10,801 | 19,313 | ||||||||||||
Interest income |
32,414 | 34,022 | 62,984 | 64,125 | ||||||||||||
Income before income taxes |
454,143 | 608,277 | 843,465 | 1,173,501 | ||||||||||||
Provision for income taxes |
151,636 | 196,833 | 278,582 | 358,581 | ||||||||||||
Net income |
$ | 302,507 | $ | 411,444 | $ | 564,883 | $ | 814,920 | ||||||||
Earnings per share: |
||||||||||||||||
Basic |
$ | 0.22 | $ | 0.30 | $ | 0.41 | $ | 0.59 | ||||||||
Diluted |
$ | 0.22 | $ | 0.29 | $ | 0.41 | $ | 0.58 | ||||||||
Weighted average number of shares: |
||||||||||||||||
Basic |
1,356,705 | 1,391,076 | 1,363,975 | 1,392,477 | ||||||||||||
Diluted |
1,373,314 | 1,407,255 | 1,379,071 | 1,408,224 |
April 27, | October 28, | |||||||
(In thousands) | 2008 | 2007 | ||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 1,098,259 | $ | 1,202,722 | ||||
Short-term investments |
1,357,097 | 1,166,857 | ||||||
Accounts receivable, net |
1,729,487 | 2,049,427 | ||||||
Inventories |
1,626,239 | 1,313,237 | ||||||
Deferred income taxes |
450,187 | 426,471 | ||||||
Other current assets |
345,669 | 448,879 | ||||||
Total current assets |
6,606,938 | 6,607,593 | ||||||
Long-term investments |
1,392,504 | 1,362,425 | ||||||
Property, plant and equipment |
2,766,315 | 2,782,204 | ||||||
Less: accumulated depreciation and amortization |
(1,692,513 | ) | (1,730,962 | ) | ||||
Net property, plant and equipment |
1,073,802 | 1,051,242 | ||||||
Goodwill, net |
1,176,122 | 1,006,410 | ||||||
Purchased technology and other intangible assets, net |
456,920 | 373,178 | ||||||
Equity method investment |
95,708 | 115,060 | ||||||
Deferred income taxes and other assets |
168,956 | 146,370 | ||||||
Total assets |
$ | 10,970,950 | $ | 10,662,278 | ||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Current portion of long-term debt |
$ | 2,749 | $ | 2,561 | ||||
Accounts payable and accrued expenses |
2,598,891 | 2,221,516 | ||||||
Income taxes payable |
105,785 | 157,549 | ||||||
Total current liabilities |
2,707,425 | 2,381,626 | ||||||
Long-term debt |
202,000 | 202,281 | ||||||
Other liabilities |
350,721 | 256,962 | ||||||
Total liabilities |
3,260,146 | 2,840,869 | ||||||
Stockholders equity: |
||||||||
Common stock |
13,554 | 13,857 | ||||||
Additional paid-in capital |
5,004,030 | 4,658,832 | ||||||
Retained earnings |
11,265,710 | 10,863,291 | ||||||
Treasury stock |
(8,575,054 | ) | (7,725,924 | ) | ||||
Accumulated other comprehensive income |
2,564 | 11,353 | ||||||
Total stockholders equity |
7,710,804 | 7,821,409 | ||||||
Total liabilities and stockholders equity |
$ | 10,970,950 | $ | 10,662,278 | ||||
Six Months Ended | ||||||||
April 27, | April 29, | |||||||
(In thousands) | 2008 | 2007 | ||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | 564,883 | $ | 814,920 | ||||
Adjustments required to reconcile net income to cash provided by
operating activities: |
||||||||
Depreciation and amortization |
154,321 | 123,978 | ||||||
Loss on fixed asset retirements |
21,527 | 12,476 | ||||||
Restructuring and asset impairments |
49,496 | 21,766 | ||||||
Deferred income taxes |
(38,538 | ) | (7,553 | ) | ||||
Excess tax benefits from equity-based compensation plans |
(5,406 | ) | (3,243 | ) | ||||
Acquired in-process research and development expense |
| 4,900 | ||||||
Net recognized loss (gain) on investments |
(3,560 | ) | 3,129 | |||||
Pretax loss of equity-method investment |
19,352 | 9,861 | ||||||
Equity-based compensation |
89,044 | 82,823 | ||||||
Changes in operating assets and liabilities, net of amounts acquired: |
||||||||
Accounts receivable, net |
385,830 | (71,064 | ) | |||||
Inventories |
(277,478 | ) | (62,442 | ) | ||||
Other current assets |
116,352 | 2,969 | ||||||
Other assets |
(4,875 | ) | (3,483 | ) | ||||
Accounts payable and accrued expenses |
195,040 | (36,546 | ) | |||||
Income taxes payable |
(11,803 | ) | (3,725 | ) | ||||
Other liabilities |
9,548 | 5,565 | ||||||
Cash provided by operating activities |
1,263,733 | 894,331 | ||||||
Cash flows from investing activities: |
||||||||
Capital expenditures |
(137,699 | ) | (131,266 | ) | ||||
Cash paid for acquisitions, net of cash acquired |
(235,324 | ) | (127,677 | ) | ||||
Proceeds from disposition of assets held for sale |
| 17,727 | ||||||
Proceeds from sales and maturities of investments |
1,285,365 | 1,400,576 | ||||||
Purchases of investments |
(1,530,288 | ) | (1,484,869 | ) | ||||
Cash provided (used) for investing activities |
(617,946 | ) | (325,509 | ) | ||||
Cash flows from financing activities: |
||||||||
Short-term debt repayments |
(12 | ) | (302 | ) | ||||
Proceeds from common stock issuances |
308,463 | 169,884 | ||||||
Common stock repurchases |
(899,984 | ) | (532,015 | ) | ||||
Excess tax benefits from equity-based compensation plans |
5,406 | 3,243 | ||||||
Payment of dividends to stockholders |
(164,274 | ) | (139,489 | ) | ||||
Cash used for financing activities |
(750,401 | ) | (498,679 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents |
151 | 438 | ||||||
Increase in cash and cash equivalents |
(104,463 | ) | 70,581 | |||||
Cash and cash equivalents beginning of period |
1,202,722 | 861,463 | ||||||
Cash and cash equivalents end of period |
$ | 1,098,259 | $ | 932,044 | ||||
Supplemental cash flow information: |
||||||||
Cash payments for income taxes |
$ | 167,185 | $ | 365,012 | ||||
Cash payments for interest |
$ | 7,229 | $ | 14,049 |
Three Months Ended | Six Months Ended | |||||||||||||||||||
April 27, | January 27, | April 29, | April 27, | April 29, | ||||||||||||||||
(In thousands, except per share amounts) | 2008 | 2008 | 2007 | 2008 | 2007 | |||||||||||||||
Non-GAAP Net Income |
||||||||||||||||||||
Reported net income (GAAP basis) |
$ | 302,507 | $ | 262,376 | $ | 411,444 | $ | 564,883 | $ | 814,920 | ||||||||||
Equity-based compensation expense |
50,322 | 38,722 | 47,922 | 89,044 | 82,822 | |||||||||||||||
Certain items associated with acquisitions 1 |
31,144 | 31,038 | 23,725 | 62,182 | 37,105 | |||||||||||||||
Restructuring and asset impairments 2,3,4 |
510 | 48,986 | 25,044 | 49,496 | 21,766 | |||||||||||||||
Costs associated with ceasing development of
beamline implant products 5 |
259 | 1,021 | 50,299 | 1,280 | 50,299 | |||||||||||||||
Resolution of audits of prior years income
tax filings6 |
| | | | (29,863 | ) | ||||||||||||||
Income tax effect of non-GAAP adjustments |
(23,142 | ) | (37,326 | ) | (49,239 | ) | (60,468 | ) | (62,673 | ) | ||||||||||
Non-GAAP net income |
$ | 361,600 | $ | 344,817 | $ | 509,195 | $ | 706,417 | $ | 914,376 | ||||||||||
Non-GAAP Net Income Per Diluted Share |
||||||||||||||||||||
Reported net income per diluted share
(GAAP basis) |
$ | 0.22 | $ | 0.19 | $ | 0.29 | $ | 0.41 | $ | 0.58 | ||||||||||
Equity-based compensation expense |
0.03 | 0.02 | 0.02 | 0.05 | 0.04 | |||||||||||||||
Certain items associated with acquisitions |
0.02 | 0.02 | 0.01 | 0.03 | 0.02 | |||||||||||||||
Restructuring and asset impairments |
| 0.02 | 0.01 | 0.02 | 0.01 | |||||||||||||||
Costs associated with ceasing development
of beamline implant products |
| | 0.02 | | 0.02 | |||||||||||||||
Resolution of audits of prior years income
tax filings |
| | | | (0.02 | ) | ||||||||||||||
Non-GAAP net income per diluted share |
$ | 0.26 | $ | 0.25 | $ | 0.36 | $ | 0.51 | $ | 0.65 | ||||||||||
Shares used in diluted shares calculation |
1,373,314 | 1,383,886 | 1,407,255 | 1,379,071 | 1,408,224 |
1 | Incremental charges attributable to acquisitions consisting of inventory fair value adjustments on products sold and amortization of purchased intangible assets. Results for the three and six months ended April 29, 2007 included an in-process research and development charge of $5 million associated with the acquisition of the software division of Brooks Automation, Inc. in the second fiscal quarter of 2007. | |
2 | Results for the six months ended April 27, 2008 included restructuring charges of $38 million associated with a global cost reduction plan. | |
3 | Results for the fiscal quarters ended April 27, 2008, January 27, 2008 and April 29, 2007 included restructuring and asset impairment charges of $510,000, $11 million and $25 million, respectively, associated with ceasing development of beamline implant products. Results for the three and six months ended April 29, 2007 included restructuring and asset impairment charges of $25 million associated with ceasing development of beamline implant products. | |
4 | Results for the three and six months ended April 29, 2007 included a net benefit of $3 million from the sale of the Hillsboro, Oregon facility. | |
5 | Results for the fiscal quarters ended April 27, 2008, January 27, 2008 and April 29, 2007 included other operating charges of $259,000, $1 million, and $50 million, respectively, associated with ceasing development of beamline implant products. | |
6 | Results for the six months ended April 29, 2007 consisted of a $24 million benefit from the resolution of audits of prior years income tax filings and a $6 million benefit related to the retroactive reinstatement to January 1, 2006 of the research and development tax credit. |